US$ 28.75
tirzepatide semaglutide differences Retatrutide vs vs tirzepatide semaglutide weight loss comparison
Description
Semaglutide is an injectable medication that belongs to the glucagon-like peptide-1 (GLP-1) receptor agonist class of medications

However, eligibility criteria, NHS commissioning rules, and important safety considerations mean these treatments are not suitable for everyone

In the UK, any medicine must hold a valid Marketing Authorisation granted by the MHRA before it can be legally sold or supplied for medicinal purposes

If you had these symptoms before starting GLP-1 therapy and they're worsening rather than improving on treatment, that's inconsistent with GLP-1 side effects and warrants formal endocrine evaluation
With Mochi Health, you can ensure you're on the right track towards achieving your weight loss goals while managing any side effects effectively